Search
for
Sort by
Research 931–960 of 1000+
- Hydrogel forming microneedles loaded with VEGF and Ritlecitinib/polyhydroxyalkanoates nanoparticles for mini-invasive androgenetic alopecia treatment
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Atopic diseases and the risk of alopecia areata among pre-teens and teenagers in Taiwan
- Medical Dermatology
- Case Report of a Patient With Psoriasis Vulgaris, Psoriatic Arthritis and Alopecia Universalis Successfully Treated With Tofacitinib and Methotrexate
- Skin Pigmentation Types, Causes and Treatment—A Review
- Identification of skin-expressed genes possibly associated with wool growth regulation of Aohan fine wool sheep
- Randomized clinical trial of astaxanthin supplement on serum inflammatory markers and ER stress‐apoptosis gene expression in PBMCs of women with PCOS
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- Minoxidil Sulfate Regulates JAK / STAT Signalling and Mitochondrial Function in Alopecia Areata
- Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata
- LB943 Tofacitinib treatment of inflammatory skin conditions in patients with Down Syndrome
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- 918 Tissue engineered human hair follicles from genetically, environmentally and extrinsically reprogrammed dermal papilla cells
- Investigating the roles of cellular senescence in embryogenesis and aging
- Tofacitinib: The selected selective JAK inhibitor in paediatric dermatology
- Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
- Apremilast and tofacitinib exert differential effects in the humanized mouse model of alopecia areata
- Alopecia areata
- Short-term malignancy risk of JAK inhibitors in severe alopecia areata: a multicenter cohort study
- Treatment Response to JAK Inhibitors in Long-standing Alopecia Areata (≥8 Years): A Real-world Observational Study
- Differences in activation of β-catenin in outer root sheath cells between the type of JAK inhibitor: An alternative mechanism promoting hair growth by JAK inhibitors in alopecia areata
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Alopecia Areata: Current and Emerging Therapies
- <i>IKZF1</i> and Ikaros Overexpression Results in Alopecia Areata‐Like Phenotype in Mice
- Advances in the mechanism and new therapies of alopecia areata
- Aging of hair follicle stem cells and their niches
- Therapeutic Options to Refractory Alopecia Areata
- 1363 Hair follicle growth and pigmentation during ageing